Medical Technology

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 4 years ago

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

@xconomy.com 4 years ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 4 years ago

SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 4 years ago

Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business

@xconomy.com 5 years ago

Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Quest Analytics Buys Healthcare Compliance Software Firm BetterDoctor

@xconomy.com 6 years ago

Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers

@xconomy.com 6 years ago

United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed